Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
110M
-
Shares change
-
+3.74M
-
Total reported value, excl. options
-
$1.46B
-
Value change
-
+$55M
-
Put/Call ratio
-
1.61
-
Number of buys
-
59
-
Number of sells
-
-49
-
Price
-
$13.31
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2015
138 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2015.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110M shares
of 363M outstanding shares and own 30.19% of the company stock.
Largest 10 shareholders include Artal Group S.A. (57.5M shares), FMR LLC (15.5M shares), UBS ASSET MANAGEMENT AMERICAS INC (8.45M shares), Ulys, L.L.C. (4.32M shares), VANGUARD GROUP INC (2.98M shares), NEA Management Company, LLC (2.38M shares), BlackRock Fund Advisors (2.19M shares), BRIDGER MANAGEMENT, LLC (1.44M shares), STATE STREET CORP (1.4M shares), and LOOMIS SAYLES & CO L P (1.11M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.